TRDA   $15.06  10.33% Market Open

Entrada Therapeutics Inc
Total Cash 469.75M
totalCashPerShare 13.35
EBITDA 96.87M
Total Debt 64.44M
quickRatio 5.58
currentRatio 5.705
Total Revenue 239.40M
debtToEquity 14.989
Revenue/Share 7.128
ROA 0.10857
ROE 0.32801
grossProfits
freeCashflow 25.43M
operatingCashflow -14.19M
earningsGrowth
revenueGrowth 4.212
grossMargins 0.53581
ebitdaMargins 0.40463
operatingMargins 0.56416
profitMargins 0.43627998
enterpriseValue 122.50M
forwardPE -4.2869563
floatShares 18.20M
sharesOutstanding 37.20M
sharesShort 2.14M
sharesShortPriorMonth 1.96M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.13%
heldPercentInstitutions 0.80%
Short Ratio help_outline 15.05%
shortPercentOfFloat 0.09%
impliedSharesOutstanding
bookValue 12.222
Price To Book help_outline 1.21
earningsQuarterlyGrowth
netIncomeToCommon 104.44M
trailingEps 3.02%
forwardEps -3.45%
enterpriseToEbitda 1.26
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.73 3Q 2024
institutionsCount 137
lastUpdated Sept. 16, 2024, 8:42 p.m.